期刊档案 · 医学-外周血管病
Clinical Hemorheology and Microcirculation
ISSN 1386-0291 · eISSN 1875-8622 · SAGE Publications (formerly IOS Press) · NETHERLANDS · Bimonthly · 创刊 1997
Clinical Hemorheology and Microcirculation 中科院 医学 4区(2025 年升级版),影响因子 2.49,订阅期刊,APC 约 4,150 美元,录用比例容易(社区反馈),2025 年发文 58 篇,SCIE、Scopus 收录,有预警或收录变动提示,请谨慎投稿。
研究范围
研究范围与定位
Clinical Hemorheology and Microcirculation 由 SAGE Publications (formerly IOS Press) 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Blood properties and coagulation、Erythrocyte Function and Pathophysiology、Trauma, Hemostasis, Coagulopathy, Resuscitation 等主题的论文,这 3 个主题约占 48.4%。(根据 OpenAlex 主题统计与中科院分区数据生成)
Clinical Hemorheology and Microcirculation, a peer-reviewed international scientific journal, serves as an aid to understanding the flow properties of blood and the relationship to normal and abnormal physiology. The rapidly expanding science of hemorheology concerns blood, its components and the blood vessels with which blood interacts. It includes perihemorheology, i.e., the rheology of fluid and structures in the perivascular and interstitial spaces as well as the lymphatic system. The clinical aspects include pathogenesis, symptomatology and diagnostic methods, and the fields of prophylaxis and therapy in all branches of medicine and surgery, pharmacology and drug research. The endeavour of the Editors-in-Chief and publishers of Clinical Hemorheology and Microcirculation is to bring together contributions from those working in various fields related to blood flow all over the world. The editors of Clinical Hemorheology and Microcirculation are from those countries in Europe, Asia, Australia and America where appreciable work in clinical hemorheology and microcirculation is being carried out. Each editor takes responsibility to decide on the acceptance of a manuscript. He is required to have the manuscript appraised by two referees and may be one of them himself. The executive editorial office, to which the manuscripts have been submitted, is responsible for rapid handling of the reviewing process. Clinical Hemorheology and Microcirculation accepts original papers, brief communications, mini-reports and letters to the Editors-in-Chief. Review articles, providing general views and new insights into related subjects, are regularly invited by the Editors-in-Chief. Proceedings of international and national conferences on clinical hemorheology (in original form or as abstracts) complete the range of editorial features.
来源:LetPub
研究方向(LetPub):医学-外周血管病
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Blood properties and coagulationMedicine29.3%
- Erythrocyte Function and PathophysiologyMedicine14.2%
- Trauma, Hemostasis, Coagulopathy, ResuscitationMedicine4.9%
- Hemoglobinopathies and Related DisordersMedicine4.1%
- Lipid metabolism and disordersMedicine3.7%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine3%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine3%
- Ultrasound and Hyperthermia ApplicationsEngineering2.9%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 4 区 |
| 小类 | 外周血管病PERIPHERAL VASCULAR DISEASE | 4 区 |
Top 期刊:否综述期刊:否
《新锐期刊分区表》( 2026年3月发布)医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 4 区 |
| 小类 | 外周血管病PERIPHERAL VASCULAR DISEASE | 4 区 |
Top 期刊:否综述期刊:未标注
期刊分区表( 2023年12月旧的升级版)医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 4 区 |
| 小类 | 外周血管病PERIPHERAL VASCULAR DISEASE | 4 区 |
Top 期刊:否综述期刊:否
数据库收录
SCIEScopusLetPub
预警 / 风险提示:2026年03月发布的新锐学术版:预警原因:Under Review 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 2.49LetPub ·
- 影响因子(出版商公布)
- 1.7出版商官网 ·
- 五年影响因子(出版商公布)
- 1.6出版商官网 ·
- CiteScore 2026-06
- 4.1LetPub ·
- SJR 2026-06
- 0.66LetPub ·
- SNIP 2026-06
- 0.55LetPub ·
- h-index
- 48LetPub ·
- h-index
- 64OpenAlex ·
- i10-index
- 1,218OpenAlex ·
- 两年平均被引
- 2.31OpenAlex ·
- 自引率
- 17.6%LetPub ·
- Gold OA 文章占比
- 4.21%LetPub ·
发文规模
- 年文章数
- 61LetPub ·
逐年发文量 OpenAlex 统计 · 累计 3,650 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 21 | 0 | 3 |
| 2025 | 58 | 6 | 46 |
| 2024 | 93 | 20 | 349 |
| 2023 | 125 | 35 | 732 |
| 2022 | 103 | 29 | 832 |
| 2021 | 138 | 21 | 1,238 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均录用比例(社区反馈)
- 容易LetPub ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊,文章需订阅或购买阅读,通常不收取版面费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / GBP 3,043 | — | — | |
| 出版商官网 | USD 400 / GBP 350 | — | — |
其他费用与减免(作者指南)
- 投稿费
- USD 400
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点5 项,摘自作者指南
- 摘要
- ≤ 200 词
- 参考文献格式
- Vancouver 格式
- 首次投稿格式
- 允许不按期刊格式排版(free format)
- 推荐审稿人
- 可选
- 投稿信(Cover letter)
- 必须提供
接收的文章类型9 种
- brief communicationOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- brief communicationsBrief communications未说明篇幅
- letterOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- letters to the editors-in-chiefLetters to the Editors-in-Chief未说明篇幅
- mini reportsMini reports未说明篇幅
- original research articleOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- research articleOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- review articleOriginal Research Article Research Articles should present novel work within the scope of the journal which represents an important advancement in knowledge or …未说明篇幅
- review articlesReview articles, providing general views and new insights into related subjects, are regularly invited by the Editors-in-Chief.未说明篇幅
官网政策摘录作者资格、数据可用性、出版伦理、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
- 作者资格 Author contributions
该期刊在投稿过程中要求列出每位作者的贡献,并要求在致谢部分之后加入 模型中文摘要
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
原文 ↗出版商官网 ·- 数据可用性 Data availability
该期刊致力于促进研究的开放性、透明度和可重复性,鼓励作者在相关公共数据存储库中共享研究数据,并包含链接到数据的可用性声明;如果无法共享数据,则使用该声明确认无法共享的原因,并在研究中引用该数据。 模型中文摘要
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
原文 ↗出版商官网 ·- 出版伦理 Ethical considerations
作者需在指定标题下包含伦理批准声明,即使已在方法部分包含伦理批准信息;如果不需要伦理批准,则需明确说明。所有报告涉及人类参与者、人类数据或人体组织的研究的论文必须声明相关伦理委员会或机构审查委员会批准了该研究,或豁免了批准要求,并提供审查委员会的全名和机构以及批准编号。 模型中文摘要
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
原文 ↗出版商官网 ·- 开放获取 Publishing fees and open access
文章被接受发表时,作者需支付400美元/350英镑的出版费;彩色印刷图片的费用由作者承担。可通过Sage Choice计划或开放获取协议选择付费开放获取出版,具体折扣或免费取决于与Sage的协议。 模型中文摘要
When an article is accepted for publication, authors are required to pay a publication fee of $400/£350 . It is possible to have figures printed in color, provided the cost of their reproduction is paid for by the author. See Preparation of Manuscripts for the required file formats. Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, wher…
原文 ↗出版商官网 ·- 同行评审 Peer review policy
该期刊采用单盲同行评审,评审者与编辑互动,不公布评审信息。稿件将首先进行初步评估,不符合指南要求的稿件将在同行评审前退回修改;超出期刊范围或不合适的稿件可能会在此时被直接拒稿。通过初步评估后,稿件将进行同行评审。 模型中文摘要
The following summary describes the peer review process for this journal: Identity transparency:Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk reject…
原文 ↗出版商官网 ·- 查重 Plagiarism
该期刊和Sage非常重视版权侵权、抄袭或其他违反出版最佳实践的问题,建议作者阅读Sage关于抄袭的完整政策及可能采取的措施。 模型中文摘要
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
原文 ↗出版商官网 ·- 预印本 Preprints
该期刊接受已在预印本服务器上发布的稿件,投稿时需在指定字段输入预印本DOI,并建议在投稿时告知期刊编辑部;在同行评审期间不应在预印本服务器上发布更新版本。 模型中文摘要
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical trial registration
该期刊遵循ICMJE要求,临床试验需在WHO批准的公共试验注册机构注册,且需在首次招募参与者时或之前完成;根据AllTrials运动,如果迟注册的理由可接受,回顾性注册的试验也将被考虑。试验注册机构名称、URL和注册号必须包含在摘要末尾。 模型中文摘要
The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- SAGE Publications (formerly IOS Press)
- 出版国家或地区
- NETHERLANDS
- 出版语言
- English
- 出版周期
- Bimonthly
- 创刊年份
- 1997
- ISSN
- 1386-0291
- 电子版 ISSN
- 1875-8622
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Clinical Hemorheology and Microcirculation 的常见问题
Clinical Hemorheology and Microcirculation 是中科院几区期刊?
2025 年升级版分区表中,Clinical Hemorheology and Microcirculation 为医学 4区,小类 血液学 / 外周血管病 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Clinical Hemorheology and Microcirculation 的影响因子是多少?
LetPub 汇总的最新公布影响因子为 2.49,CiteScore 为 4.1,h-index 为 64。
Clinical Hemorheology and Microcirculation 的投稿格式要求是什么?
据期刊作者指南:摘要:≤ 200 词;参考文献格式:Vancouver 格式;首次投稿格式:允许不按期刊格式排版(free format);推荐审稿人:可选;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Clinical Hemorheology and Microcirculation 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Clinical Hemorheology and Microcirculation 被 SCIE、Scopus 收录。
Clinical Hemorheology and Microcirculation 是开放获取期刊吗?版面费多少?
Clinical Hemorheology and Microcirculation 为订阅期刊。APC 约 4,150 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-24 归档)。最近更新:。